Skip to content

Clinical trials

Completed Scleroderma, Systemic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Completed Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20082
20101
20113
20121
20142
20154
20161
20181
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion3
Boehringer Ingelheim3
Charite University, Berlin, Germany3
Hoffmann-La Roche2
ISDIN2
ARCIM Institute Academic Research in Complementary and Integrative Medicine1
Active Biotech AB1
Bayer1
Heidelberg University1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic23
Raynaud Disease3
Scleroderma, Diffuse2
Fibrosis1
Graft vs Host Disease1
Hypertension, Pulmonary1
Peripheral Vascular Diseases1
Scleroderma, Localized1
Ulcer1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.